TB Biosciences, Inc. — Form D
TB Biosciences, Inc. of BETHLEHEM, PA, a company, filed a Form D exempt-offering notice with the SEC on 2013-06-12. The offering totals $1.5M, of which $1.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2013-06-12
- Form: D
- Accession: 0001578956-13-000002
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $1.5M
- Amount sold: $1.3M
- Remaining: $250K
- Investors: 9
- Date of first sale: 2013-05-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-197829
Issuer
- Name: TB Biosciences, Inc.
- CIK: 0001578956
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 205 WEBSTER STREET, BETHLEHEM, PA, 18015
- Phone: 610-597-5501
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| MICHAEL SAM GAUSLING | Director | BETHLEHEM, PA |
| R. SAM NIEDBALA | Director | BETHLEHEM, PA |
| DAVID SAM OXELY | Director | BETHLEHEM, PA |
| R. SAM NIEDBALA | Executive Officer | BETHLEHEM, PA |
More